Safety and Efficacy of the Soluble Guanylate Cyclase Stimulator Praliciguat in Patients with Heart Failure with Preserved Ejection Fraction (Capacity HFpEF): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

被引：0
|
作者：
Udelson, James E. [1 ]
Lewis, Gregory D. [2 ]
Shah, Sanjiv J. [3 ]
Zile, Michael R. [4 ,5 ]
Redfield, Margaret M. [6 ]
Burnett, John [6 ]
Parker, John D. [7 ]
Seferovic, Jelena [8 ]
Wilson, Phebe J. [8 ]
Mittleman, Robert S. [9 ]
Profy, Albert T. [8 ]
Konstam, Marvin A. [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA 02111 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Med Univ South Carolina, Charleston, SC 29425 USA
[5] RHJ Dept VA Med Ctr, Charleston, SC USA
[6] Mayo Clin, Rochester, MN USA
[7] Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada
[8] Cycler Therapeut, Boston, MA USA
[9] Ironwood Pharmaceut, Cambridge, MA USA
来源：
JOURNAL OF CARDIAC FAILURE | 2020年 / 26卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
014
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] Rationale and design for a multicenter, randomized, double-blind, placebo- controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)
    Udelson, James E.
    Lewis, Gregory D.
    Shah, Sanjiv J.
    Zile, Michael R.
    Redfield, Margaret M.
    Burnett, John, Jr.
    Mittleman, Robert S.
    Profy, Albert T.
    Seferovic, Jelena P.
    Reasner, David
    Konstam, Marvin A.
    AMERICAN HEART JOURNAL, 2020, 222 : 183 - 190
  • [2] Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Soluble Guanylate Cyclase Stimulator Praliciguat in Patients with Diabetic Kidney Disease
    Hanrahan, John P.
    de Boer, Ian
    Bakris, George
    Wilson, Phebe
    Wakefield, James D.
    Seferovic, Jelena P.
    Chickering, Jennifer
    Cressman, Michael
    Currie, Mark
    Milne, George T.
    Profy, Albert T.
    DIABETES, 2020, 69
  • [3] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator The VICTORIA Trial
    Armstrong, Paul W.
    Roessig, Lothar
    Patel, Mahesh J.
    Anstrom, Kevin J.
    Butler, Javed
    Voors, Adriaan A.
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Temple, Tracy
    Pieske, Burkert
    Ezekowitz, Justin
    Hernandez, Adrian F.
    Koglin, Joerg
    O'Connor, Christopher M.
    JACC-HEART FAILURE, 2018, 6 (02) : 96 - 104
  • [4] The effect of Aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: A randomized, placebo-controlled, double-blind trial
    Upadhya, Bharathi
    Brubaker, Peter H.
    Morgan, Timothy M.
    Eggebeen, Joel D.
    Jao, Geoffrey T.
    Stewart, Kathryn P.
    Kitzman, Dalane W.
    AMERICAN HEART JOURNAL, 2018, 201 : 164 - 167
  • [5] Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease A Randomized Placebo-Controlled Clinical Trial
    Hanrahan, John P.
    de Boer, Ian H.
    Bakris, George L.
    Wilson, Phebe J.
    Wakefield, James D.
    Seferovic, Jelena P.
    Chickering, Jennifer G.
    Chien, Yueh-tyng
    Carlson, Kenneth
    Cressman, Michael D.
    Currie, Mark G.
    Milne, G. Todd
    Profy, Albert T.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (01): : 59 - 69
  • [6] The Efficacy and Safety of Xinmailong Injection in Patients with Chronic Heart Failure: A Multicenter Randomized Double-Blind Placebo-Controlled Trial
    Xue, Jingui
    Xu, Yong
    Deng, Yue
    Li, Fengchun
    Liu, Fan
    Liu, Li
    Wang, Xing
    Wang, Jianzhong
    Wang, Xiaolong
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (08) : 856 - 860
  • [7] Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial
    Jamialahmadi, Tannaz
    Hasanpour, Maede
    Vakilian, Farveh
    Penson, Peter E.
    Iranshahy, Milad
    Sahebkar, Amirhossein
    REVIEWS ON RECENT CLINICAL TRIALS, 2024, 19 (03) : 221 - 228
  • [8] A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN™ IN PATIENTS WITH CHRONIC HEART FAILURE
    Gao, Runlin
    Zhang, Jian
    Liu, Heping
    Wang, Lina
    Pang, Xiaohua
    Fu, Lu
    Meng, Fanbo
    Zhou, Mingdong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 668 - 668
  • [9] Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
    Tal Y. Samuel
    Tal Hasin
    Israel Gotsman
    Tanya Weitzman
    Fanny Ben Ivgi
    Ziv Dadon
    Elad Asher
    Offer Amir
    Michael Glikson
    Ronny Alcalai
    David Leibowitz
    Drugs in R&D, 2022, 22 : 25 - 33
  • [10] Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
    Samuel, Tal Y.
    Hasin, Tal
    Gotsman, Israel
    Weitzman, Tanya
    Ben Ivgi, Fanny
    Dadon, Ziv
    Asher, Elad
    Amir, Offer
    Glikson, Michael
    Alcalai, Ronny
    Leibowitz, David
    DRUGS IN R&D, 2022, 22 (01) : 25 - 33
12345